Zoetis Inc. (ETR: ZOE)

Market Cap	71.40B
Revenue (ttm)	8.21B
Net Income (ttm)	2.18B
Shares Out	n/a
EPS (ttm)	4.77
PE Ratio	32.77
Forward PE	n/a
Dividend	1.60 (0.94%)
Ex-Dividend Date	Jan 21, 2025

Volume	675
Open	158.50
Previous Close	158.28
Day's Range	158.50 - 159.36
52-Week Range	136.70 - 185.00
Beta	0.89
Analysts	n/a
Price Target	n/a
Earnings Date	Feb 14, 2025

About Zoetis

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1952
• Employees: 14,100
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: ZOE

Financial Performance

In 2023, Zoetis's revenue was $8.54 billion, an increase of 5.74% compared to the previous year's $8.08 billion. Earnings were $2.34 billion, an increase of 10.88%.

Financial numbers in USD